Compare Vanguard Real Estate Index Fund ETF (VNQ) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Real Estate Index Fund ETF vs GeneDx Holdings Corp — how do they compare? Vanguard Real Estate Index Fund ETF trades at $99.52, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Vanguard Real Estate Index Fund ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| VNQ | WGS | |
|---|---|---|
52-Week High | $100.07 | $167.51 |
52-Week Low | $87.00 | $34.51 |
Market Cap | — | $1.80B |
Sector | — | Technology |
Enterprise Value | — | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VNQ trades at $99.50, down 0.52% today, with technical indicators showing a bullish moving average trend but neutral oscillators. The ETF holds a dominant position in U.S. real estate with a low expense ratio of 0.13% (The Motley Fool, 2026-07-18). Recent news highlights strong year-to-date performance and comparisons with competing REIT ETFs.
Outlook remains positive due to sector momentum and income appeal, though risks include interest rate sensitivity and potential overvaluation signals from RSI levels. The dividend schedule provides income stability, but macroeconomic factors could pressure near-term performance.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
